Cohort1: TriMix_dose Level
|
Administration route |
intranodal administration |
Dosage |
TriMix mRNA, 100mg, 3 immunizations (at weeks 0, 2 and 4) |
Pts |
3 |
Age |
Adult, Older_Adult |
References |
PMID:
30289805
|
|
Cohort2: TriMix_dose Leve2
|
Administration route |
intranodal administration |
Dosage |
TriMix mRNA, 300mg, 3 immunizations (at weeks 0, 2 and 4) |
Pts |
3 |
Age |
Adult, Older_Adult |
References |
PMID:
30289805
|
|
Cohort3: HIVACAT_dose Level_TriMix_dose Leve2
|
Administration route |
intranodal administration |
Dosage |
HIVACAT mRNA, 600mg and TriMix mRNA, 300mg, 3 immunizations (at weeks 0, 2 and 4) |
Pts |
3 |
Age |
Adult, Older_Adult |
References |
PMID:
30289805
|
|
Cohort4: HIVACAT_dose Leve2_TriMix_dose Leve2
|
Administration route |
intranodal administration |
Dosage |
HIVACAT mRNA, 900mg and TriMix mRNA, 300mg, 3 immunizations (at weeks 0, 2 and 4) |
Pts |
3 |
Age |
Adult, Older_Adult |
References |
PMID:
30289805
|
|
Cohort5: HIVACAT_dose Leve3_TriMix_dose Leve2
|
Administration route |
intranodal administration |
Dosage |
HIVACAT mRNA, 1200mg and TriMix mRNA, 300mg, 3 immunizations (at weeks 0, 2 and 4) |
Pts |
6 |
Age |
Adult, Older_Adult |
References |
PMID:
30289805
|
|